Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
218 studies found for:    "Idiopathic pulmonary fibrosis"
Show Display Options
RSS Create an RSS feed from your search for:
"Idiopathic pulmonary fibrosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
2 Recruiting Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Omeprazole;   Drug: Matched placebo
3 Unknown  Exercise Training at Ambulatory Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis Patients
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Behavioral: Pulmonary Rehabilitation
4 Recruiting Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: FG-3019;   Drug: Placebo
5 Recruiting Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
6 Recruiting Using MRI to Visualize Regional Therapy Response in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Hyperpolarized 129-Xenon gas;   Device: MRI
7 Completed
Has Results
Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: ACT-064992 (macitentan);   Drug: Placebo
8 Unknown  The Role of Gastric Content Microaspirations in the Pathogenesis of Idiopathic Pulmonary Fibrosis
Condition: IDIOPATHIC PULMONARY FIBROSIS
Intervention:
9 Unknown  Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot Study
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: minocycline
10 Completed
Has Results
A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: Placental MSC
11 Withdrawn A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Standard Steroid Treatment;   Drug: The Standard Steroid Treatment, Plasma Exchange and rituximab
12 Recruiting Study of Autologous Mesenchymal Stem Cells to Treat Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Biological: Endobronchial infusion of adult mesenchymal stem cells;   Biological: Autologous mesenchymal stem cells derived from bone marrow
13 Not yet recruiting Yoga Effect on Quality of Life Study Among Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: Yoga
14 Active, not recruiting The Effect of Pirfenidone on Cough in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: Cough monitor
15 Completed Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: Standard pulmonary rehabilitation program
16 Recruiting Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Cotrimoxazole;   Drug: Placebo
17 Withdrawn Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Macitentan
18 Completed Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
19 Recruiting Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
20 Recruiting A Safety and Tolerability Study of Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Pirfenidone;   Drug: Vismodegib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.